BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2008 related articles for article (PubMed ID: 8431856)

  • 1. Cutaneous malignant melanoma of the head and neck. Analysis of treatment results and prognostic factors in 581 patients: a report from the Swedish Melanoma Study Group.
    Ringborg U; Afzelius LE; Lagerlöf B; Adami HO; Augustsson I; Blomqvist E; Boeryd B; Carlin E; Edström S; Eldh J
    Cancer; 1993 Feb; 71(3):751-8. PubMed ID: 8431856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective population-based study of cutaneous malignant melanoma of the head and neck.
    Gillgren P; Månsson-Brahme E; Frisell J; Johansson H; Larsson O; Ringborg U
    Laryngoscope; 2000 Sep; 110(9):1498-504. PubMed ID: 10983950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group.
    Cox NH; Aitchison TC; Sirel JM; MacKie RM
    Br J Cancer; 1996 Apr; 73(7):940-4. PubMed ID: 8611411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cutaneous malignant melanoma in the area of the head and neck with intermediate tumor thickness: does primary site have prognostic relevance?].
    Wenzel S; Metternich FU; Sagowski C; Neuber K; Kehrl W
    Laryngorhinootologie; 2001 Jun; 80(6):313-7. PubMed ID: 11475610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden.
    Thörn M; Pontén F; Bergström R; Sparén P; Adami HO
    J Natl Cancer Inst; 1994 May; 86(10):761-9. PubMed ID: 8169974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment.
    Urist MM; Balch CM; Soong SJ; Milton GW; Shaw HM; McGovern VJ; Murad TM; McCarthy WH; Maddox WA
    Ann Surg; 1984 Dec; 200(6):769-75. PubMed ID: 6508408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
    Hoersch B; Leiter U; Garbe C
    Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant melanoma of the head and neck in Scotland: an eight-year analysis of trends in prevalence, distribution and prognosis.
    Cox NH; Jones SK; MacKie RM
    Q J Med; 1987 Aug; 64(244):661-70. PubMed ID: 3444872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with 998 cutaneous melanomas of the head and neck over 30 years.
    O'Brien CJ; Coates AS; Petersen-Schaefer K; Shannon K; Thompson JF; Milton GW; McCarthy WH
    Am J Surg; 1991 Oct; 162(4):310-4. PubMed ID: 1951880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in head and neck melanoma. Effect of lesion location.
    Wanebo HJ; Cooper PH; Young DV; Harpole DH; Kaiser DL
    Cancer; 1988 Aug; 62(4):831-7. PubMed ID: 3395962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous melanoma of the head and neck.
    Loree TR; Spiro RH
    Am J Surg; 1989 Oct; 158(4):388-91. PubMed ID: 2802047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological characteristics of cutaneous malignant melanoma of the head and neck--a population-based study.
    Gillgren P; Månsson-Brahme E; Frisell J; Johansson H; Larsson O; Ringborg U
    Acta Oncol; 1999; 38(8):1069-74. PubMed ID: 10665765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous melanoma of the head and neck.
    Vreeburg GC; Schouwenburg PF; Hilgers FJ; de Kraker NW; Hart AA
    Eur J Surg Oncol; 1988 Apr; 14(2):165-70. PubMed ID: 3360158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin melanoma of the head and neck. Prognostic factors and recurrence-free survival in 512 patients.
    Andersson AP; Gottlieb J; Drzewiecki KT; Hou-Jensen K; Sondergaard K
    Cancer; 1992 Mar; 69(5):1153-6. PubMed ID: 1739914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program.
    Lachiewicz AM; Berwick M; Wiggins CL; Thomas NE
    Arch Dermatol; 2008 Apr; 144(4):515-21. PubMed ID: 18427046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous malignant melanoma in south Sweden 1965, 1975, and 1985. A histopathologic review.
    Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
    Cancer; 1994 Mar; 73(6):1625-30. PubMed ID: 8156490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
    Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
    Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of neck dissection in the treatment of patients with intermediate-thickness cutaneous malignant melanoma of the head and neck.
    Myers JN
    Arch Otolaryngol Head Neck Surg; 1999 Jan; 125(1):110-5. PubMed ID: 9932599
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary cutaneous melanoma. Prognostic classification of anatomic location.
    Garbe C; Büttner P; Bertz J; Burg G; d'Hoedt B; Drepper H; Guggenmoos-Holzmann I; Lechner W; Lippold A; Orfanos CE
    Cancer; 1995 May; 75(10):2492-8. PubMed ID: 7736393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile malignant melanoma of the head and neck.
    Fisher SR; Reintgen DS; Seigler HF
    Laryngoscope; 1988 Feb; 98(2):184-9. PubMed ID: 3339930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 101.